Registry of Lobbyists
Subject matters | Details | Categories |
---|---|---|
Budget,
Health,
Industry,
Intellectual Property,
Research and Development,
Science and Technology
|
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, specifically aspects related to the pharmaceutical and life sciences sector, including intellectual property protection and attraction of investments in research and development.
|
Policies or Program
|
Budget,
Health,
Industry,
Research and Development,
Science and Technology
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s Biomanufacturing and Life Sciences Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
|
Policies or Program
|
Budget,
Health,
Industry
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with Canada's Drug Agency and/or other pan-Canadian health organizations.
|
Policies or Program
|
Budget,
Health,
Industry
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board.
|
Regulation
|
Subject matters | Details | Categories |
---|---|---|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, specifically aspects related to the pharmaceutical and life sciences sector, including intellectual property protection and attraction of investments in research and development.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new research and biomanufacturing capacity for Canada.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with the Canadian Agency for Drugs and Technologies in Health (CADTH) and/or other pan-Canadian health organizations.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board.
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Implementation of the Biomanufacturing and Life Sciences Strategy by ISED and Health Canada.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
|
Policies or Program
|
Communication techniques that have been used or are expected to be used in the course of the undertaking: